Stephan Pleschka

researcher

Stephan Pleschka is …
instance of (P31):
humanQ5

P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q28219439Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity
Q34059292Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.
Q30382531Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)
Q30406177Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo
Q37985804Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury
Q40249148Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence
Q39997525Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex
Q37416247Borna disease virus: a unique pathogen and its interaction with intracellular signalling pathways
Q39764205Caspase 3 activation is essential for efficient influenza virus propagation
Q33780480Constitutive activation of the transcription factor NF-kappaB results in impaired borna disease virus replication
Q34672221Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial
Q34459383Efficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segments
Q36419847Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade.
Q38758541Identification of specific residues in avian influenza A virus NS1 that enhance viral replication and pathogenicity in mammalian systems
Q30352337Improved dual promotor-driven reverse genetics system for influenza viruses.
Q30375878In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A Viruses
Q38714315Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.
Q35785139Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses
Q35641245Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes
Q35076991Influenza-virus-induced signaling cascades: targets for antiviral therapy?
Q39530571Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo
Q33830136Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses
Q37019615Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand
Q40538886Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice
Q40580039MEK inhibition impairs influenza B virus propagation without emergence of resistant variants
Q36737913Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection
Q27336255Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia
Q27863918Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling
Q40556029NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation
Q41821502NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response
Q42203103Origin of the European avian-like swine influenza viruses
Q30423206Overview of Influenza Viruses
Q39923490Phylogenetic analysis of human influenza A/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains.
Q37247071RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade
Q40549133Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3.
Q30427954Reassortment of NS segments modifies highly pathogenic avian influenza virus interaction with avian hosts and host cells.
Q34388691Replication and adaptive mutations of low pathogenic avian influenza viruses in tracheal organ cultures of different avian species.
Q30250982Ribonuclease from Bacillus Acts as an Antiviral Agent against Negative- and Positive-Sense Single Stranded Human Respiratory RNA Viruses
Q36392204Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells
Q28830060The Influenza A Virus Genotype Determines the Antiviral Function of NF-κB
Q40258089The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo
Q41951682The NS segment of H5N1 avian influenza viruses (AIV) enhances the virulence of an H7N1 AIV in chickens.
Q33614553The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV
Q30383298The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.
Q39685168The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors
Q57093653Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview

Search more.